{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:14:57Z","timestamp":1783091697270,"version":"3.54.6"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022719","name":"Darwin Trust of Edinburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["085944"],"award-info":[{"award-number":["085944"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bbrc.2025.152938","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T05:46:32Z","timestamp":1763185592000},"page":"152938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Biophysical and functional characterization of IgE interactions with a malaria antigen"],"prefix":"10.1016","volume":"792","author":[{"given":"Abdulrahman I.","family":"Adam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4363-7568","authenticated-orcid":false,"given":"Brian J.","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9037-2980","authenticated-orcid":false,"given":"James M.","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbrc.2025.152938_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri2273","article-title":"IgE in allergy and asthma today","volume":"8","author":"Gould","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"7203","key":"10.1016\/j.bbrc.2025.152938_bib2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature07204","article-title":"The development of allergic inflammation","volume":"454","author":"Galli","year":"2008","journal-title":"Nature"},{"issue":"S6760","key":"10.1016\/j.bbrc.2025.152938_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/35037021","article-title":"Signalling through the high-affinity IgE receptor Fc\u03b5RI","volume":"402","author":"Turner","year":"1999","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbrc.2025.152938_bib4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12016-022-08955-9","article-title":"New mechanistic advances in Fc\u03b5RI-Mast cell\u2013mediated allergic signaling","volume":"63","author":"Li","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152938_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00281-016-0565-1","article-title":"IgE and mast cells in host defense against parasites and venoms","volume":"38","author":"Mukai","year":"2016","journal-title":"Semin. Immunopathol."},{"issue":"6459","key":"10.1016\/j.bbrc.2025.152938_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/367183a0","article-title":"High-affinity IgE receptor on eosinophils is involved in defence against parasites","volume":"367","author":"Soussi","year":"1994","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bbrc.2025.152938_bib7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm.4512","article-title":"A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite","volume":"24","author":"Kisalu","year":"2018","journal-title":"Nat. Med."},{"issue":"e21","key":"10.1016\/j.bbrc.2025.152938_bib8","article-title":"Human antibodies that slow erythrocyte invasion potentiate malaria-neutralizing antibodies","volume":"228","author":"Alanine","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152938_bib9","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1038\/s41598-019-40321-2","article-title":"Inhibition of parasite invasion by monoclonal antibody against epidermal growth factor-like domain of Plasmodium vivax merozoite surface protein 1 paralog","volume":"9","author":"Han","year":"2019","journal-title":"Sci. Rep."},{"issue":"e8","key":"10.1016\/j.bbrc.2025.152938_bib10","article-title":"A potent anti-malarial human monoclonal antibody targets circumsporozoite protein minor repeats and neutralizes sporozoites in the liver","volume":"744","author":"Wang","year":"2020","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.bbrc.2025.152938_bib11","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41591-020-0881-9","article-title":"Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs","volume":"26","author":"Murugan","year":"2020","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152938_bib12","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1038\/s41598-021-84622-x","article-title":"In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP","volume":"11","author":"Livingstone","year":"2021","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bbrc.2025.152938_bib13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/psp4.12224","article-title":"Pharmacokinetics of monoclonal antibodies","volume":"6","author":"Ryman","year":"2017","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152938_bib14","first-page":"109","article-title":"IgE immunotherapy against cancer","volume":"vol. 388","author":"Leoh","year":"2015"},{"issue":"4","key":"10.1016\/j.bbrc.2025.152938_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1398-9995.2007.01601.x","article-title":"Geohelminth infections: a review of the role of IgE and assessment of potential risks of Anti\u2010IgE treatment","volume":"63","author":"Cooper","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.bbrc.2025.152938_bib16","series-title":"World Malaria Report 2024: Addressing Inequity in the Global Malaria Response","year":"2024"},{"issue":"8","key":"10.1016\/j.bbrc.2025.152938_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161607","article-title":"A comprehensive analysis of plasmodium circumsporozoite protein binding to hepatocytes","volume":"11","author":"Zhao","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbrc.2025.152938_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1084\/jem.20101488","article-title":"The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to Mammalian host","volume":"208","author":"Coppi","year":"2011","journal-title":"J. Exp. Med."},{"issue":"9988","key":"10.1016\/j.bbrc.2025.152938_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152938_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1172\/JCI70349","article-title":"Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection","volume":"124","author":"Foquet","year":"2014","journal-title":"J. Clin. Investig."},{"issue":"48","key":"10.1016\/j.bbrc.2025.152938_bib21","doi-asserted-by":"crossref","first-page":"E10438","DOI":"10.1073\/pnas.1715812114","article-title":"Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein","volume":"114","author":"Oyen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bbrc.2025.152938_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143958","article-title":"Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention","volume":"6","author":"Kisalu","year":"2021","journal-title":"JCI Insight"},{"issue":"5885","key":"10.1016\/j.bbrc.2025.152938_bib23","article-title":"A tool kit for rapid cloning and expression of recombinant antibodies","volume":"4","author":"Dodev","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.152938_bib24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymeth.2003.11.002","article-title":"FuGENE 6 transfection reagent: the gentle power","volume":"33","author":"Jacobsen","year":"2004","journal-title":"Methods"},{"key":"10.1016\/j.bbrc.2025.152938_bib25","series-title":"Protein-Ligand Interactions: Hydrodynamics and Calorimetry","author":"Van Der Merwe","year":"2001"},{"issue":"1\u20132","key":"10.1016\/j.bbrc.2025.152938_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-1759(02)00369-1","article-title":"RBL cells expressing human Fc epsilon RI are a sensitive tool for exploring functional IgE-allergen interactions: studies with sera from peanut-sensitive patients","volume":"274","author":"Dibbern","year":"2003","journal-title":"J. Immunol. Methods"},{"issue":"7","key":"10.1016\/j.bbrc.2025.152938_bib27","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.4049\/jimmunol.1900509","article-title":"Interplay between affinity and valency in effector cell degranulation: a model system with polcalcin allergens and human patient\u2013derived IgE antibodies","volume":"203","author":"Bucaite","year":"2019","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152938_bib28","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220323","article-title":"Highly protective antimalarial antibodies via precision library generation and yeast display screening","volume":"219","author":"Banach","year":"2022","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.bbrc.2025.152938_bib29","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.immuni.2021.10.017","article-title":"Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies","volume":"54","author":"Kratochvil","year":"2021","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.bbrc.2025.152938_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112903","article-title":"In silico improvement of affinity for highly protective anti-malarial antibodies","volume":"28","author":"Reveiz","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.bbrc.2025.152938_bib31","series-title":"Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and steady-state Enzyme Systems","author":"Segel","year":"2001"},{"key":"10.1016\/j.bbrc.2025.152938_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/abio.1993.1450","article-title":"Circular dichroic analysis of denatured proteins: inclusion of denatured proteins in the reference set","volume":"214","author":"Venyaminov","year":"1993","journal-title":"Anal. Biochem."},{"issue":"39","key":"10.1016\/j.bbrc.2025.152938_bib33","doi-asserted-by":"crossref","first-page":"26951","DOI":"10.1074\/jbc.M109.013706","article-title":"Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate","volume":"284","author":"Plassmeyer","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152938_bib34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nsmb.2795","article-title":"Human immunoglobulin E flexes between acutely bent and extended conformations","volume":"21","author":"Drinkwater","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"6614","key":"10.1016\/j.bbrc.2025.152938_bib35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/385336a0","article-title":"Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes","volume":"385","author":"Menard","year":"1997","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bbrc.2025.152938_bib36","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/emboj\/21.7.1586","article-title":"Levels of circumsporozoite protein in the plasmodium oocyst determine sporozoite morphology","volume":"21","author":"Thathy","year":"2002","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.bbrc.2025.152938_bib37","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1021\/cb7001472","article-title":"Trivalent ligands with rigid DNA spacers reveal structural requirements for IgE receptor signaling in RBL mast cells","volume":"2","author":"Sil","year":"2007","journal-title":"ACS Chem. Biol."},{"issue":"44","key":"10.1016\/j.bbrc.2025.152938_bib38","doi-asserted-by":"crossref","first-page":"12739","DOI":"10.1021\/bi034884l","article-title":"Highly effective Poly(Ethylene glycol) architectures for specific inhibition of immune receptor activation","volume":"42","author":"Baird","year":"2003","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.bbrc.2025.152938_bib39","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1038\/s41591-025-03739-y","article-title":"Anti-sporozoite monoclonal antibody for malaria prevention: secondary efficacy outcome of a phase 2 randomized trial","volume":"31","author":"Skinner","year":"2025","journal-title":"Nat. Med."},{"issue":"17","key":"10.1016\/j.bbrc.2025.152938_bib40","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJMoa2312775","article-title":"Subcutaneous administration of a monoclonal antibody to prevent malaria","volume":"390","author":"Kayentao","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152938_bib41","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1038\/s41467-023-39679-9","article-title":"Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial","volume":"14","author":"Spicer","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152938_bib42","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2025.2451295","article-title":"Physiochemical and functional evaluation of the first-in-class anti-cancer IgE antibody drug, MOv18, through process development and good manufacturing practice production","volume":"17","author":"Bax","year":"2025","journal-title":"mAbs"},{"issue":"2","key":"10.1016\/j.bbrc.2025.152938_bib43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1067\/mai.2000.107931","article-title":"Negative regulation of FcepsilonRI signaling by FcgammaRII costimulation in human blood basophils","volume":"106","author":"Kepley","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152938_bib44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1710-1492-2-3-87","article-title":"Coaggregation of FcepsilonRI with FcgammaRIIB inhibits degranulation but not induction of Bcl-2 family members A1 and bim in mast cells","volume":"2","author":"Ekoff","year":"2006","journal-title":"Allergy Asthma Clin. Immunol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25016547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25016547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:51:48Z","timestamp":1773802308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25016547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":44,"alternative-id":["S0006291X25016547"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152938","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biophysical and functional characterization of IgE interactions with a malaria antigen","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152938"}}